A randomized, placebo-controlled trial of effects of dexamethasone on hypothalamic-pituitary-adrenal axis in preterm infants

https://doi.org/10.1016/S0022-3476(88)80398-6Get rights and content

As part of a blinded, randomized, placebo-controlled study of dexamethasone therapy in 27 preterm infants with bronchopulmonary dysplasia, we investigated the effect of 7 days of high-dose glucocorticoid therapy on the hypothalamic-pituitary-adrenal axis. Before therapy the median basal cortisol concentration in all infants was 8.2 μg/dl (226 nmol/L). After stimulation with 1–24 ACTH, the serum cortisol concentration rose in all infants to a median concentration of 23.5 μg/dl (649 nmol/L), resulting in a median rise of 13.4 μg/dl (37 nmol/L). Immediately after 7 days of glucocorticoid therapy basal and peak cortisol concentrations were significantly decreased in the dexamethasone group. The rise in serum cortisol following 1–24 ACTH, however, remained equivalent in both groups. Ten days after the end of therapy basal and peak cortisol concentrations in the dexamethasone group had returned to levels equivalent to those seen in the placebo group. Weight gain was markedly diminished while the infants were receiving dexamethasone. Weight gains were, however, equivalent 10 days after the end of treatment. These data indicate that 7 days of dexamethasone therapy has significant but short-term effects on cortisol secretion and possibly on weight gain.

References (20)

There are more references available in the full text version of this article.

Cited by (63)

  • Fetal and Neonatal Endocrinology

    2010, Endocrinology: Adult and Pediatric, Sixth Edition
  • Impact of perinatal corticosteroids on neuromotor development and outcome: Review of the literature and new meta-analysis

    2009, Seminars in Fetal and Neonatal Medicine
    Citation Excerpt :

    In recent years, a number of additional trials have reported long-term follow-up data and one important additional RCT has been reported. In order to enhance this discussion, we have conducted a new meta-analysis of the RCTs that compared dexamethasone with placebo and that have reported long-term follow-up.5,28–32,34–45 These studies were identified by review of previous analyses together with an updated Medline search.

  • Repeat doses of antenatal steroids and hypothalamic-pituitary-adrenal axis (HPA) function

    2007, American Journal of Obstetrics and Gynecology
    Citation Excerpt :

    After prolonged postnatal dexamethasone use for chronic lung disease, a transient suppression of HPA axis activity is reported to occur.19-21 Importantly, the adrenal gland is not the only site of suppression, and longer-term effects at the level of the pituitary and hypothalamus37 are still consistent with the reported failure to demonstrate longer-term suppression with the use of ACTH stimulation tests.20,23 Because in the clinical setting false reassurance regarding HPA axis status could lead to delays in supportive treatment for stressed infants, it has been suggested that the ACTH test is insufficient to exclude HPA axis suppression in the neonate.21

View all citing articles on Scopus

Supported by research grants HL34118-03 (RLA) and RR00081 from the National Institutes of Health.

Presented in part at the American Thoracic Society, New Orleans, 1987 (Am Rev Respir Dis 1987; 135:A125).

View full text